Boots gives launch of French skincare product to St Luke’s

Boots Healthcare International has picked St Luke’s to help with the UK launch of a new range of skincare products, Lutsia Laboratoires’ so-called dermacostics.

Boots Healthcare International has picked St Luke’s to help with

the UK launch of a new range of skincare products, Lutsia Laboratoires’

so-called dermacostics.



Dermacostics are positioned mid-way between the glamour of expensive

skincare brands and the clinical rigour of dermatological lines such as

Boots E45.



Boots is attempting to move beyond straightforward retail by developing

a sizeable international brand portfolio.



Boots acquired the French company, Lutsia, from Roussel Uclaf for pounds

115 million last year. In France, it markets Lutsine, an anti-acne

product and Onagrine, an anti-ageing cream, with combined sales worth

around pounds 40 million.



The Lutsia range will make its first appearance in February next year as

part of a new offering designed to help problem skin. The campaign

breaks in April.



The advertising business, which is expected to be worth around pounds 1

million, was awarded without a pitch. St Luke’s already handles Boots’

17 and No 7 ranges of cosmetics.